Amy S Paul Form 4 WRIGHT MEDICAL / AMY S PAUL ownership change

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:	3235-0287
Estimated average burden
hours per response:	0.5

X

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

1. Name and Address of Reporting Person^*

PAUL AMY S

(Last) (First) (Middle)

2591 BRENTWOOD DRIVE

(Street)

HOLLADAY UT 84121

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
WRIGHT MEDICAL GROUP INC [ WMGI ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director	10% Owner
	Officer (give title below)	Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
10/01/2015

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	10/01/2015		D		29,700	D	(1)	0	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Outside Director Stock Option (Right to Buy)	$29.19	10/01/2015		D			15,000	(2)	05/14/2018	Common Stock	15,000	(3)	0	D
Outside Director Stock Option (Right to Buy)	$15.47	10/01/2015		D			10,000	(2)	05/13/2019	Common Stock	10,000	(4)	0	D
Outside Director Stock Option (Right to Buy)	$18.37	10/01/2015		D			10,000	(2)	05/13/2020	Common Stock	10,000	(5)	0	D
Outside Director Stock Option (Right to Buy)	$15.5	10/01/2015		D			10,000	(2)	05/11/2021	Common Stock	10,000	(6)	0	D
Outside Director Stock Option (Right to Buy)	$21.39	10/01/2015		D			10,000	(2)	05/09/2022	Common Stock	10,000	(7)	0	D
Outside Director Stock Option (Right to Buy)	$24.66	10/01/2015		D			10,000	(2)	05/14/2023	Common Stock	10,000	(8)	0	D
Outside Director Stock Option (Right to Buy)	$29.95	10/01/2015		D			10,000	(2)	05/13/2024	Common Stock	10,000	(9)	0	D

Explanation of Responses:

1. Disposed of pursuant to the Agreement and Plan of Merger by and among the issuer, Tornier N.V., Trooper Holdings Inc., and Trooper Merger Sub Inc., which became effective on October 1, 2015, in exchange for 30,617 Wright Medical Group N.V. ("Wright N.V.") ordinary shares having a market value of $20.39 per share at the effective time of the merger.

2. The outside director stock option vests in equal annual installments over a period of four years after the grant date.

3. This option was assumed by Wright N.V. in the merger and replaced with an option to purchase 15,463 Wright N.V. at a price of $28.32 per share.

4. This option was assumed by Wright N.V. in the merger and replaced with an option to purchase 10,309 Wright N.V. at a price of $15.01 per share.

5. This option was assumed by Wright N.V. in the merger and replaced with an option to purchase 10,309 Wright N.V. at a price of $17.82 per share.

6. This option was assumed by Wright N.V. in the merger and replaced with an option to purchase 10,309 Wright N.V. at a price of $15.04 per share.

7. This option was assumed by Wright N.V. in the merger and replaced with an option to purchase 10,309 Wright N.V. at a price of $20.75 per share.

8. This option was assumed by Wright N.V. in the merger and replaced with an option to purchase 10,309 Wright N.V. at a price of $23.93 per share.

9. This option was assumed by Wright N.V. in the merger and replaced with an option to purchase 10,309 Wright N.V. at a price of $29.06 per share.

Remarks:

	/s/ Marija S. Nelson, Attorney-in-fact	10/05/2015
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.